Paasa Logo
Giant Biogene Holding Co., Ltd. logo
2367HKSEMarket closedOpens 9:30am HKT

Giant Biogene Holding Co., Ltd.

HK$24.28Last updated
+HK$0.24 (1.00%)Past day
Timezone

Giant Biogene Holding Co., Ltd. (HKSE: 2367) is trading at HK$24.28, about ₹297 at today's HKD/INR rate, as of 28 Sep 2026, 4:08 AM ET, up 1.00% today. Indian residents can buy Giant Biogene Holding from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:HK$24.08
Previous close:HK$24.04
Volume:1.64M

Today's low

HK$24.08

Today's high

HK$24.86

52 week low

HK$23.62

52 week high

HK$57.25

2367 opened at HK$24.08, closed previously at HK$24.04, and has traded between HK$23.62 and HK$57.25 over the past 52 weeks.

About

Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.

Country
CN
CEO
Jianya Yan
Exchange listed on
HKSE
Industry
Household & Personal Products
Base currency
HKD
Full Time Employees
2,319
Sector
Consumer Defensive
IPO date
04/11/2022

Key statistics

Avg. volume

4.58M

Market cap

HK$25.78B

P/E Ratio

13.31

Price-to-sales ratio

4.17

Enterprise value

CN¥17.21B

Free cash flow yield

8.28%

Debt-to-equity ratio

0.00

Return on equity

17.22%

ROIC

14.77%

Beta

0.73

Dividend yield

5.72%

Last dividend

HK$2.70

Financial overview

Revenue

CN¥5.52B

Earnings per share

CN¥1.83

Free cash flow

CN¥1.48B

Net profit margin

31.41%

Gross margin

79.07%

EBITDA

CN¥2.19B

Revenue growth

-0.37%

Similar securities

This is not an investment recommendation

How to buy Giant Biogene Holding from India

Indian residents can buy Giant Biogene Holding shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.

  3. Search for Giant Biogene Holding and place an order

    Find Giant Biogene Holding by name or by its ticker, 2367, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Giant Biogene Holding trades 7:00 am – 1:30 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Giant Biogene Holding position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Giant Biogene Holding from India

Trading and taxes when buying Giant Biogene Holding from India

Trading and limits

Trading hours
9:30 am – 4:00 pm HKT
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Giant Biogene Holding’s current yield is 5.72%.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Giant Biogene Holding stock?

Yes. Giant Biogene Holding (2367) has been listed on the Hong Kong Stock Exchange since 2022, in the Household & Personal Products industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Giant Biogene Holding share cost in rupees?

One Giant Biogene Holding share is HK$24.28 — about ₹297 at an HKD/INR rate of 12.24 on 27 Sep 2026. Both the Giant Biogene Holding price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Giant Biogene Holding from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Giant Biogene Holding?

Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.

How are gains on Giant Biogene Holding shares taxed in India?

Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Giant Biogene Holding price. Paasa issues a capital-gains statement for your return.

Does Giant Biogene Holding pay a dividend, and how is it taxed in India?

Yes. Giant Biogene Holding pays a dividend and the current yield is 5.72%; the last declared dividend was HK$2.70 per share, about ₹32.98. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Giant Biogene Holding from India?

The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.

Is Giant Biogene Holding a Hong Kong SAR China company, and does that change how it is taxed?

Giant Biogene Holding trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Giant Biogene Holding trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Do I have to declare Giant Biogene Holding shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Giant Biogene Holding holding, its cost and its closing value.

How do I sell Giant Biogene Holding and bring the money back to India?

You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.